{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:55:17Z","timestamp":1780394117279,"version":"3.54.1"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"34","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,11,3]]},"DOI":"10.18632\/oncotarget.5358","type":"journal-article","created":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T00:16:32Z","timestamp":1444954592000},"page":"35813-35829","source":"Crossref","is-referenced-by-count":41,"title":["High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis"],"prefix":"10.18632","volume":"6","author":[{"given":"Minzhi","family":"Hou","sequence":"first","affiliation":[{"name":"Department of Pathology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Province Guangdong, P.R. China"},{"name":"Department of Gynecology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Province Guangdong, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Pathology, ShenZhen People's Hospital, Second Clinical Medical College of Jinan University, Shenzhen, Guangdong, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Gynecology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Province Guangdong, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanyang","family":"He","sequence":"additional","affiliation":[{"name":"Department of Gynecology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Province Guangdong, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Province Guangdong, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Stomatology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Province Guangdong, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongjin","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Stomatology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Province Guangdong, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Biostatistics, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Biomedical Engineering, University of Texas at El Paso, El Paso, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millicent","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging (CIMI), California NanoSystems Institute (CNSI), University of California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liantang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Province Guangdong, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunfu","family":"Ke","sequence":"additional","affiliation":[{"name":"Department of Pathology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Province Guangdong, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,10,3]]},"reference":[{"key":"1","first-page":"225","article-title":"Cancer Statistics","volume":"59","author":"Thun","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Forman","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1056\/NEJMcp0901926","article-title":"Clinical practice. Screening for ovarian cancer","volume":"361","author":"Clarke-Pearson","year":"2009","journal-title":"N Engl J Med"},{"key":"4","first-page":"S161","article-title":"Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Beller","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molmed.2008.03.004","article-title":"Epithelial-mesenchymal transition and the invasive potential of tumors","volume":"14","author":"Ben-Ze'ev","year":"2008","journal-title":"Trends Mol Med"},{"key":"6","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1172\/JCI44871","article-title":"Wnt\/\u03b2-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium","volume":"121","author":"Morrisey","year":"2011","journal-title":"J Clin Invest"},{"key":"7","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1158\/1078-0432.CCR-06-0030","article-title":"Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers","volume":"12","author":"Zhou","year":"2006","journal-title":"Clin Cancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/01.RES.0000154262.07264.12","article-title":"Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration","volume":"96","author":"Lindner","year":"2005","journal-title":"Circ Res"},{"key":"9","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1349-7006.2012.02292.x","article-title":"CTHRC1 is upregulated by promoter demethylation and transforming growth factor-\u03b21 and may be associated with metastasis in human gastric cancer","volume":"103","author":"Fang","year":"2012","journal-title":"Cancer Sci"},{"key":"10","doi-asserted-by":"crossref","first-page":"10825","DOI":"10.3748\/wjg.v20.i31.10825","article-title":"Novel therapeutic targets for pancreatic cancer","volume":"20","author":"Chen","year":"2014","journal-title":"World J Gastroenterol"},{"key":"11","doi-asserted-by":"crossref","first-page":"20217","DOI":"10.1074\/jbc.M113.473785","article-title":"N-glycosylation induces the CTHRC1 protein and drives oral cancer cell migration","volume":"288","author":"Kukuruzinska","year":"2013","journal-title":"J Biol Chem"},{"key":"12","doi-asserted-by":"crossref","first-page":"9410","DOI":"10.18632\/oncotarget.2421","article-title":"Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer","volume":"5","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"key":"13","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/prca.201400063","article-title":"Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies","volume":"8","author":"Jacobs","year":"2014","journal-title":"Proteomics Clin Appl"},{"key":"14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neo.2014.03.001","article-title":"CTHRC1 acts as a prognostic factor and promotes invasiveness of gastrointestinal stromal tumors by activating Wnt\/PCP-Rho signaling","volume":"16","author":"Zhang","year":"2014","journal-title":"Neoplasia"},{"key":"15","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s12253-013-9636-y","article-title":"Collagen triple helix repeat containing-1 (CTHRC1) expression in invasive ductal carcinoma of the breast: the impact on prognosis and correlation to clinicopathologic features","volume":"19","author":"Kim","year":"2013","journal-title":"Pathol Oncol Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"key":"17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0032-1328320","article-title":"Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian Cancer","volume":"73","author":"du Bois","year":"2013","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10456-010-9199-4","article-title":"Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer","volume":"14","author":"Boxer","year":"2011","journal-title":"Angiogenesis"},{"key":"19","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","article-title":"Incorporation of bevacizumab in the primary treatment of ovarian cancer","volume":"365","author":"Birrer","year":"2011","journal-title":"N Engl J Med"},{"key":"20","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMoa1103799","article-title":"A phase 3 trial of bevacizumab in ovarian cancer","volume":"365","author":"Parmar","year":"2011","journal-title":"N Engl J Med"},{"key":"21","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1021\/jm300185p","article-title":"Design and synthesis of pyrrolo[3,2-d]pyrimidine human epidermal growth factor receptor 2 (HER2)\/epidermal growth factor receptor (EGFR) dual inhibitors: exploration of novel back-pocket binders","volume":"55","author":"Ishikawa","year":"2012","journal-title":"J Med Chem"},{"key":"22","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1038\/onc.2012.527","article-title":"\u03b2-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced \u03b2-catenin signaling","volume":"32","author":"Bagnato","year":"2013","journal-title":"Oncogene"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22249","article-title":"PTN signaling: Components and mechanistic insights in human ovarian cancer","author":"Godwin","year":"2014","journal-title":"Mol Carcinog"},{"key":"24","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1007\/s13277-013-1401-z","article-title":"Clinical significance of serum epithelial cell adhesion molecule (EPCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in patients with epithelial ovarian cancer","volume":"35","author":"Duranyildiz","year":"2014","journal-title":"Tumour Biol"},{"key":"25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/cam4.115","article-title":"Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment","volume":"2","author":"Mor","year":"2013","journal-title":"Cancer Med"},{"key":"26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jprot.2014.03.042","article-title":"Proteomic analysis of cancer and mesothelial cells reveals an increase in Mucin 5AC during ovarian cancer and peritoneal interaction","volume":"103","author":"Diamandis","year":"2014","journal-title":"J Proteomics"},{"key":"27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1755-8794-6-53","article-title":"Integrated molecular portrait of non-small cell lung cancers","volume":"6","author":"Pawitan","year":"2013","journal-title":"BMC Med Genomics"},{"key":"28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/01.RES.0000154262.07264.12","article-title":"Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration","volume":"96","author":"Lindner","year":"2005","journal-title":"Circ Res"},{"key":"29","doi-asserted-by":"crossref","first-page":"e3174","DOI":"10.1371\/journal.pone.0003174","article-title":"Cthrc1 is a positive regulator of osteoblastic bone formation","volume":"3","author":"Akiyama","year":"2008","journal-title":"PLoS One"},{"key":"30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2310\/7750.2011.10014","article-title":"Collagen triple helix repeat containing 1 promotes melanoma cell adhesion and survival","volume":"15","author":"Zhou","year":"2011","journal-title":"J Cutan Med Surg"},{"key":"31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10354-014-0323-8","article-title":"Epithelial ovarian cancer-more data, more questions?","volume":"164","author":"Pils","year":"2014","journal-title":"Wien Med Wochenschr"},{"key":"33","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/carcin\/bgs378","article-title":"Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells","volume":"34","author":"Koh","year":"2013","journal-title":"Carcinogenesis"},{"key":"34","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.humpath.2013.12.020","article-title":"Cthrc1 overexpression is an independent prognostic marker in gastric cancer","volume":"45","author":"Lou","year":"2014","journal-title":"Hum Pathol"},{"key":"35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.18632\/oncotarget.1714","article-title":"Collagen triple helix repeat containing 1 (CTHRC1) acts via ERK-dependent induction of MMP9 to promote invasion of colorectal cancer cells","volume":"5","author":"Lee","year":"2014","journal-title":"Oncotarget"},{"key":"36","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1210\/jcem-39-6-1020","article-title":"Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood","volume":"39","author":"Yen","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","article-title":"Cancer metastasis: building a framework","volume":"127","author":"Massagu\u00e9","year":"2006","journal-title":"Cell"},{"key":"38","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI36183","article-title":"Biomarkers for epithelial-mesenchymal transitions","volume":"119","author":"Neilson","year":"2009","journal-title":"J Clin Invest"},{"key":"39","first-page":"4587","article-title":"E-cadherin and metastasin (mts-1\/S100A4) expression levels are inversely regulated in two tumor cell families","volume":"58","author":"van Roy","year":"1998","journal-title":"Cancer Res"},{"key":"40","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1083\/jcb.148.4.779","article-title":"Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis","volume":"148","author":"Aaronson","year":"2000","journal-title":"J Cell Biol"},{"key":"41","first-page":"4211","article-title":"Prognostic significance of N-Cadherin expression in oral squamous cell carcinoma","volume":"31","author":"Santoro","year":"2011","journal-title":"Anticancer Res"},{"key":"42","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1242\/jcs.021782","article-title":"Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium","volume":"121","author":"Munshi","year":"2008","journal-title":"J Cell Sci"},{"key":"43","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/labinvest.2012.8","article-title":"Snail overexpression induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells","volume":"92","author":"Liu","year":"2012","journal-title":"Lab Invest"},{"key":"44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.devcel.2008.05.007","article-title":"Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex","volume":"15","author":"Sasaki","year":"2008","journal-title":"Dev Cell"},{"key":"45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc2389","article-title":"Wnt signalling and its impact on development and cancer","volume":"8","author":"Birchmeier","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"46","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ijc.26102","article-title":"\u03b2-catenin as a potential key target for tumor suppression","volume":"129","author":"Zhu","year":"2011","journal-title":"Int J Cancer"},{"key":"47","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1038\/emboj.2012.150","article-title":"The many faces and functions of \u03b2-catenin","volume":"31","author":"Basler","year":"2012","journal-title":"EMBO J"},{"key":"48","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1172\/JCI43937","article-title":"Oncogenic \u03b2-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice","volume":"122","author":"Couty","year":"2012","journal-title":"J Clin Invest"},{"key":"49","doi-asserted-by":"crossref","first-page":"e78200","DOI":"10.1371\/journal.pone.0078200","article-title":"The role of nuclear \u03b2-catenin accumulation in the Twist2-induced ovarian cancer EMT","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"50","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/onc.2013.203","article-title":"Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of \u03b2-catenin activation of the DKK1 promoter in prostate cancer","volume":"33","author":"Keller","year":"2014","journal-title":"Oncogene"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T21:16:16Z","timestamp":1599686176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,3]]},"references-count":50,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2015,11,3]]}},"alternative-id":["5358","26452130"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5358","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,3]]}}}